baber/WOPTO huggingface dataset:
Patent JP-H0250447-B2 (JP)
IPC: F21V8/00
Filed: 1983-08-17
Abstract: This disclosure depicts a light source device for an endoscope, incorporating a lamp to supply the light to a light guide fiber bundle for the illumination of the endoscope. This light source device for the endoscope has a heat radiating device for the light guide fiber bundle for the illumination, which has been highly heated by the radiant heat of the lamp. The radiating device includes a support ring and radiator fins radially movably mounted to and supported by the support ring via resilient members. When a light inciding end portion of the light guide fiber bundle for the illumination is installed into the light source device for the endoscope, the heat radiating device is moved radially outwardly against the biasing forces of the resilient members, and the radiator fins are reliably brought into close contact with the outer periphery of the light inciding end portion of the light guide fiber bundle. As the result, the light source device for the endoscope according to the present invention is high in radiation efficiency and can prevent the light guide fiber bundle from being highly heated.
Patent JP-H0477581-B2 (JP)
IPC: A61C19/00
Filed: 1985-07-08
Abstract: The equipment makes it possible to cause the polymerization of resin by light, starting from the approximal-apical zone (8') of the tooth, i.e. at the base of the filling.It comprises a wedge (1) transparent to the rays used for polymerization of the resin inserted in the approximal zone (i.e., between teeth), a wedge shaped to refract or reflect the concentrated light provided it by a lighting device equipped with a cap with a converging lens, in the axial direction, deflecting and emitting it in the lateral direction 19'), so as to illuminate the filling resin with greater intensity at its base (8'), avoiding fissures (15) between the filling and base of the tooth, which would occur if the illumination were performed, as is now done (at 14) starting from the occlusal (masticatory) part of the tooth.
Patent JP-3912818-B2 (JP)
IPC: C07C55/32
Filed: 1996-06-14
Granted: 2007-05-09
Abstract: Prepn. of an optically active  alpha -(chloro or bromo)-alkanoic acid, salt or deriv. of formula R(CH2)n-CH2-CHX-COOM (I) comprises enantiomer-selective hydrogenation of an  alpha , beta -unsatd. alkenoic acid deriv. of formula (II) in presence of a ruthenium complex (III) of an optically active (pref. atropisomeric) diphosphine ligand. X = Cl or Br; M = H, N(R1)4<+>, alkali metal or alkaline earth metal cation; R1 = H or lower alkyl; n = 0 or 1; R = H or 1-20C alkyl (opt. terminally substd. by N(R2)2, COOR2, OR3, opt. protected CHO or opt. substd. ring); R2 = H or lower alkyl; R3 = H or protecting gp.
Patent JP-2529397-B2 (JP)
IPC: H01L23/14
Filed: 1989-06-16
Granted: 1996-08-28
Abstract: PURPOSE:To acquire submount having high adhesion strength with a chip component and high bonding strength by forming an electrode material of a mount section of a chip component and that of a bonding pad separately. CONSTITUTION:After SiO2 2 is formed on Si 1, Cr 3 is deposited and an inverse configuration of Sn 4 electrode is shaped by resist. Then, Au/Sn alloy and Au are deposited. Au, Au/Sn alloy on resist and resist are removed by using a step of resist, Sn excepting remaining Au/Sn alloy 5 and Au 6 electrode section is removed by etching to form an electrode of a chip component mount section. Ti 7 and Au 8 are deposited and removed by etching to form an electrode of a bonding pad. An electrode material of a chip component mount section and that of a bonding pad are formed separately in this way. Accordingly, it is possible to acquire submount having good adhesion strength with a chip component and high bonding strength of a wire bonding section.
Patent JP-3061893-B2 (JP)
IPC: A61L33/00
Filed: 1991-05-31
Granted: 2000-07-10
Abstract: A surgical tissue bag (301) for percutaneously debulking large volumes of tissue contained within the bag (301). The tissue bag (301) comprises two layers of material, an inner layer of a puncture-resistant material and an outer layer of moisture-proof material for containing cells and fluid therein. The bag (301) material is foldable and flexible for insertion through an access sheath (302) into the surgical site and for forming a gas-tight seal when extended through the access sheath (302) or puncture site. A drawstring (310) is attached to the open end of the bag (301) to close the bag (301) when the tissue is contained therein and pulled through the puncture site in the outer surface of the skin (304). After the closed open end of the bag (301) is pulled through the puncture site, the closed end is fanned out against the outer layer of the skin, and a morcellator is inserted into the bag for debulking the large volume of tissue. The open end of the bag is continully fanned out to maintain a compact and tight containment of the tissue and fluid remaining in the bag. The morcellation process is continued until the entire volume of tissue is removed at which time the remaining portion of the bag (301) is completely removed from the surgical site area.
Patent JP-H0247962-B2 (JP)
IPC: A61K6/02
Filed: 1982-09-10
Abstract: A sheet-shape adhesive preparation for promoting tooth-movement in orthodontics comprising a layer of a pharmaceutical composition containing as the active ingredient a prostaglandin (e.g. prostaglandin E1, prostaglandin E2, and prostaglandin F2 alpha ) in admixture with one or more high molecular weight compounds and a flexible base sheet, a process for the preparation thereof, and a method for promoting tooth-movement in orthodontics by applying the sheet-shape adhesive preparation to the mucous membrane of gingiva. Said preparation can be kept for a long period of time without being dissolved in saliva and without irritation or unpleasant feeling when applied to the mucous membrane of gingiva and hence can show the tooth-movement activity of the active prostaglandin for a long period of time.
Patent JP-H0788350-B2 (JP)
IPC: C07C303/40
Filed: 1987-06-29
Abstract: N-Fluorosulphonamides are prepared by reaction with fluorine in a solvent mixture.
Patent JP-3134061-B2 (JP)
IPC: F21Y101/00
Filed: 1997-06-20
Granted: 2001-02-13
Abstract: A headlamp for an automobile comprising: a light source unit having a reflector and a light source mounted therein; a housing disposed rear the light source unit and secured to a vehicle body; an aiming mechanism interposed between the light source unit and the housing, for tiltably cantilevering the light source unit; a bracket secured to a rear surface of the light source unit, for connecting the aiming mechanism; and a rearwardly extending projection provided on the rear surface of the light source unit, wherein the rearwardly extending projection abuts against the bracket to prevent the deformation of the bracket due to the self-weight of the light source unit.
Patent JP-3817756-B2 (JP)
IPC: C07H19/01
Filed: 1995-06-16
Granted: 2006-09-06
Abstract: The present invention provides a method for the purification of a 23-E isomer of a 23-imino derivative of a LL-F28249 compound having the structural formula I <CHEM>
Patent JP-3330351-B2 (JP)
IPC: D02G3/44
Filed: 1999-07-05
Granted: 2002-09-30
Abstract: An aramid multifilament yarn, preferably poly(p-phenylene terephthalamide), is coated with a water swellable superabsorbent material. The swelling value of the yarn is at least 60. The superabsorbent provides water blocking capability to the yarn, so that it is suitable for use as a strength member in water tight optical communication cables. The yarn is made by successively treating an aramid yarn with a waterin-oil emulsion, a superabsorbent material being present in the water phase of the emulsion, and removing the liquid components from the treated yarn by evaporation.
Patent JP-2771024-B2 (JP)
IPC: C08L51/06
Filed: 1990-08-30
Granted: 1998-07-02
Abstract: Disclosed is a laminate-tube container having a shoulder improved in the barrier property, which is characterized in that the shoulder comprises a material composed of (A) 0 to 50% by weight of polyethylene, (B) 10 to 50% by weight of an ethylene-vinyl alcohol copolymer or a saponified ethylene-vinyl acetate copolymer and (c) 10 to 90% by weight of a carboxylic acid-modified adhesive polyethylene resin. The laminate-tube can be markedly improved in the gas barrier property at the shoulder thereof and, thus, the quality of the contents of the container can be maintained for a long period of time. The laminate-tube container according to the present invention is greatly useful as the container to be used for toothpaste, medicine, food, drink, adhesive or the like.
Patent JP-2748333-B2 (JP)
IPC: A61P31/04
Filed: 1994-09-08
Granted: 1998-05-06
Abstract: The present invention provides a compound having one of the formulae:   <CHEM> Wherein: R1 and R6 may be the same or different and are H, alkyl or aralkyl having from 1 to 12 carbon atoms, provided that R1 and R6 are not H;  R7 is H, alkyl, aryl or aralkyl having from 1 to 12 carbon atoms;  m is an integer from 3 to 6, inclusive; and  n is an integer from 3 to 6, inclusive, or (IV), a salt thereof especially for anti-neoplastic, anti-psoriasis, anti-viral or anti-retroviral therapy or for controlling the growth of insects.
Patent JP-H0633253-B2 (JP)
IPC: C07D401/04
Filed: 1985-11-07
Abstract: Novel compounds of the formula Iand its salts; process for the preparation thereof, pharmaceutical compositions containing such compounds and their use in medicine.
Patent JP-H0723377-B2 (JP)
IPC: A61K31/40
Filed: 1990-09-27
Abstract: The present invention relates to compounds of the formula I, <CHEM> where X is hydrogen, halogen or loweralkyl; and R1, R2 and R3 are each independently hydrogen, loweralkyl, cycloalkyl, arylloweralkyl or aryl, or alternatively the group -NR2R3 taken as a whole constitutes <CHEM> R4 being hydrogen or loweralkyl and a process for their preparation. The compounds of the invention show central cholinergic innervative properties for treating various memory dysfunctions and can, therefore, be used as medicaments.
Patent JP-H074232-B2 (JP)
IPC: A01N63/50
Filed: 1985-12-09
Abstract: The invention relates to genetically engineered plant-colonizing microorganisms which proliferate in symbiotic or non-detrimental relationships with the plant in the plant environment. Such microorganisms contain DNA derived from Bacillus thuringiensis which codes for the insecticidal crystal protein toxin. The engineered plant-colonizing microorganisms of the invention and their progeny are active against a variety of lepidopterous pests. The invention further relates to the use of such plant-colonizing microorganisms in a method of killing or inhibiting lepidopterous pests and to insecticidal compositions containing the plant-colonizing microorganism as the active insecticidal agent.
Patent JP-4782262-B2 (JP)
IPC: C09D11/037
Filed: 1999-10-12
Granted: 2011-09-28
Abstract: A low dust homogeneous pigment preparation containing (wt.%): at least one effect pigments (50), a plasticizer or a plasticizer/nitrocellulose mixture (0.1-50), and solvent or solvent mixture (0-49.9) is new. A Independent claim is included for preparation of a composition involving addition to the effect pigment, simultaneously or in succession, the plasticizer, optionally the nitrocellulose, and a solvent, and then homogenization of the mixture in powder mixing unit.
Patent JP-2528599-B2 (JP)
IPC: E05B47/00
Filed: 1992-10-28
Granted: 1996-08-28
Abstract: A coded card key (14) is insertable through a slot (15) to bring into alignment coded magnetic areas on the card with magnetic pins (28) of the lock to unlock a core (24) relative to a locking plate (21) and enable the core (24) to be driven downwardly by the card engaging its lower flange (26) and to actuate an apparatus, typically a door-lock.   The core (24) has a cam having a first cam part (54) which is engageable by the card (14) and a second cam part (55) which abuts a limit spring (56) when the core (24) has reached the unlock position, whereby the core (24) keeps the unlock position as long as the card (14) engages the cam part (54). Withdrawal of the card (14) by the user allows return movement of core (24). The user can release the card for actuating e.g. a door-knob, instead of having to hold the card down in the lock while rotating the door-knob. <IMAGE>
Patent JP-3029461-B2 (JP)
IPC: H05K7/14
Filed: 1995-08-16
Granted: 2000-04-04
Abstract: A front panel system has an upper or lower endpiece (5) arranged in the upper or lower front corner area (3) of the printed circuit card (3). An upper or lower lever handle (19) arranged at the upper or lower endpiece serves to lever the printed circuit card in and out of its support. Means (25) are provided to fix the lever handles in their corresponding position when the printed circuit card is fully inserted into its support. A switching element (31) is integrated in the upper or lower endpiece. When the lever handle is in its fixed position, the switching element may be actuated by the lever handle, thus electrically disconnecting the printed circuit card. The invention has the advantage of allowing the switching element integrated in a lower or upper endpiece to be brought into an exactly definable position, so that the switching element may be permanently and reliably actuated by the lever handle even when the switching means of the switching element have only a small switching path.
Patent JP-3382940-B2 (JP)
IPC: A61K47/30
Filed: 1992-01-23
Granted: 2003-03-04
Abstract: PCT No. PCT/DE92/00043 Sec. 371 Date Nov. 24, 1993 Sec. 102(e) Date Nov. 24, 1993 PCT Filed Jan. 23, 1992 PCT Pub. No. WO92/12710 PCT Pub. Date Aug. 6, 1992.A drug formulation administrable by mouth for the treatment of central dopamine deficiency condition, said formulation comprising 100 to 250 parts by weight of levodopa, 10 to 25 parts by weight of carbidopa, a polymer mixture in an amount of 10 to 200% based on said drugs, said polymer mixture consisting of: 0 to 100 parts by weight of a completely saponified polyvinyl alcohol having 0 to 3% residual acetyl content, a mean molecular weight of 60,000 to 80,000 and a total surface area of 0.1 m2/g to 0.18 m2/g, and 0 to 100 parts weight of a partially saponified polyvinyl alcohol having 10 to 18% residual acetyl content, a mean molecular weight of 80,000, a total surface area of 0.5 m2/g to 0.69 m2/g, and a specific pore volume of 0.2 cm3/g to 0.36 cm3/g, and an effective amount of customary galenic adjuvants.
Patent JP-S6138998-B2 (JP)
IPC: F24B/
Filed: 1983-11-24
Abstract: PCT No. PCT/FR83/00227 Sec. 371 Date Jul. 20, 1984 Sec. 102(e) Date Jul. 20, 1984 PCT Filed Nov. 24, 1983 PCT Pub. No. WO84/02182 PCT Pub. Date Jun. 7, 1984.A projectile intended to be fired by a firearm comprising a rear portion of general cylindrical configuration whose diameter determines the gauge of the projectile and a front portion of general conical configuration ending in a front point. The front portion has, between the front point and the rear portion, a curved front hollow zone joined to the front point, a curved rear hollow zone connected to the rear portion, these two hollow zones being joined together by at least one curved bulge zone.
Patent JP-3051994-B2 (JP)
IPC: G01N1/10
Filed: 1990-02-12
Granted: 2000-06-12
Abstract: A liquid sampling device is provided for periodic aseptic removal of samples of a source liquid to be analyzed, comprised of a primary liquid conduit tube closed at one end and, at the other end, adapted to be in liquid communication with a principal or secondary flow line through which the source liquid flows or is arranged to flow, and a plurality of separate sample conduit tubes emanating from and in liquid communication with the primary liquid conduit tube, one end of each sample conduit tube being adapted to withdraw therethrough a sample of the source liquid. The device is configured such that, after a sample is taken through a particular sample conduit tube, that tube can be isolated or removed from the system, and subsequent samples are taken successively from remaining sample conduit tubes in the same manner.
Patent JP-3065087-B2 (JP)
IPC: B28B1/24
Filed: 1988-04-11
Granted: 2000-07-12
Abstract: A process for forming articles from inorganic sinterable particulates includes providing a well-dispersed, low pressure injectable slurry, freeze-forming the slurry into a desired geometry, and drying the piece so formed by a predominantly sublimative process, to produce a green article that can be conventionally sintered. The slurries preferably have a solids content of at least about 35 v/o, a viscosity of preferably not more than about 1000 cP at 100 s<-1>, and are preferably injectable at not more than about 1000 psi.
Patent JP-3438891-B2 (JP)
IPC: H04L12/56
Filed: 1993-09-14
Granted: 2003-08-18
Abstract: Asynchronous Transfer Mode Local Area Network (ATM LAN). The ATM LAN is implemented as a set of MAC entities which share a common group address space for the purposes of establishing multicast connections. Each station has one or more ATM MAC entities per physical connection to an ATM network. The network ATM LAN service provides the station with ATM LAN configuration information needed for ATM MAC operation. Included in this information is the number of ATM LANs the network has configured for that station.
Patent JP-3961017-B2 (JP)
IPC: B32B5/08
Filed: 1995-08-01
Granted: 2007-08-15
Abstract: A process for forming a sheet material having a fibrous surface and the sheet material produced thereby; the fibers are produced by deposition of a heated, thermally sensitive material on to a substrate, which is transported at a velocity approximately equal to the velocity of the material being deposited, by manipulating the fiber density and denier, the sheet material can be made to be either softer or rougher to the touch.
Patent JP-3532202-B2 (JP)
IPC: C08J5/00
Filed: 1993-09-23
Granted: 2004-05-31
Abstract: Porous, absorbent macrostructures that, upon contacting liquids such as water or body exudates (e.g., urine), swell and imbibe such liquids, and are useful in absorbent articles such as diapers, adult incontinence pads, and sanitary napkins are disclosed. These porous macrostructures comprise bonded absorbent particles that are surface crosslinked with cationic, preferably polymeric, amino-epichlorohydrin adducts.
Patent JP-3026841-B2 (JP)
IPC: A61K9/12
Filed: 1992-12-04
Granted: 2000-03-27
Abstract: A pharmaceutical formulation comprising (i) one or more particulate medicaments, and (ii) 1,1,1,2-tetrafuoroethane as propellant, which formulation contains less than 0.0001% w/w surfactant based upon the weight of medicament, particulate medicament being present in an amount from 00005 to 5% w/w relative to the total weight of the formulation and having a particle size of less than 100 micrions, with the proviso that said medicament is other than salmeterol, salbutamol, fluticasone propionate, beclomethasone dipropionate or a physiologically acceptable salt or solvate thereof and with the proviso that when said formulation consists of betamethasone, ergotamine tartrate or sodium cromoglycate and 1,1,1,2-tetrafluoroethane the weight to weight ratio of medicament to propellant is other than 69:7900 or 0.866% w/w.
Patent JP-2739776-B2 (JP)
IPC: A61P9/08
Filed: 1994-10-24
Granted: 1998-04-15
Abstract: PCT No. PCT/EP94/03509 Sec. 371 Date Apr. 19, 1996 Sec. 102(e) Date Apr. 19, 1996 PCT Filed Oct. 24, 1994 PCT Pub. No. WO95/13274 PCT Pub. Date May 18, 1995This invention relates to compounds of formula (I),    <IMAGE>  (I)  pharmaceutically acceptable salt thereof, and pharmaceutically acceptable solvates of either entity, wherein X is CH or N; Y is optionally monousaturated C3-C5 alkylene optionally substituted with C1-C4 alkyl or methylene; R1 is H; C1-C4 alkyl optionally substituted with C1-C4 alkoxy, OH, NR5R6, CONR5R6, C3-C6 cycloalkyl or aryl; or C3-C6 alkenyl; R2 is H; C1-C4 alkyl optionally substituted with C1-C4 alkoxy, OH, NR5R6, CONR5R6, C3-C6 cycloalkyl or aryl; or CONR5R6; R3 and R4 are each independently selected from H; C1-C4 alkyl optionally substituted with NR5R6; C1-C4 alkoxy; halo; CONR5R6 and aryl; R5 and R6 are each independently selected from H and C1-C4 alkyl; and m and n are each independently 1, 2 or 3; are potent and selective thrombin inhibitors useful in the treatment of, inter alia, deep vein thrombosis; reocclusion following thrombolytic therapy; chronic arterial obstruction; peripheral vascular disease; acute myocardial infarction; unstable angina; atrial fibrillation; thrombotic stroke; transient ischaemic attacks; restenosis and occlusion following angioplasty; or neurodegenerative disorders.
Patent JP-3056258-B2 (JP)
IPC: A61P21/00
Filed: 1995-11-14
Granted: 2000-06-26
Abstract: Disclosed herein are inhibitors of the multicatalytic protease enzyme which are represented by the general formula:   <IMAGE>   Constituent members and preferred constituent members are disclosed herein. Methodologies for making and using the disclosed compounds are also set forth herein.
Patent JP-4416839-B2 (JP)
IPC: C07K14/52
Filed: 1995-11-16
Granted: 2010-02-17
Abstract: A method of treating cellular immune deficiency in a patient including the steps of determining the presence of a cellular immune deficiency and co-administering to the patient an effective amount of a thymic peptide combined with an effective amount of an immunomodulating natural cytokine preparation.
Patent JP-2813466-B2 (JP)
IPC: H04M3/48
Filed: 1994-01-28
Granted: 1998-10-22
Abstract: A method of effecting automatic callback in a mobile telecommunication system. A calling subscriber is permanently connected to a public switched telephone network and a called subscriber is a mobile unit which moves in the public land mobile network. A centrally located home location register keeps an account of where all mobiles registered in the mobile telecommunication network are located, with the aid of local databases, so-called visitor location registers. The called subscriber calls the called subscriber and finds that the subscriber is busy. The calling subscriber then dials a code, wherewith a reference is stored in a queue in the home location register, this queue relating to the called subscriber. When the called subscriber is free to receive a call, the calling subscriber is informed to this effect. The calling subscriber then lifts his telephone receiver and a connection is set-up between the two subscribers. When the called subscriber answers, the call is considered to have been connected. The home location register (HLR) then removes the reference from the queue.
Patent JP-2761294-B2 (JP)
IPC: C12P7/64
Filed: 1994-04-22
Granted: 1998-06-04
Abstract: The invention concerns triglyceride compositions as obtainable by 1,3-specific enzymic interesterification of: 1) a triglyceride mix, comprising > 30 % P and/or St, from which > 35 % is bonded at 2, while the remaining fatty acid residues are mainly unsaturated; 2) a triglyceride mix, wherein > 10 % of 1,3-positions are accompanied by C8-C14 fatty acids.
Patent JP-4283340-B2 (JP)
IPC: A23L19/00
Filed: 1997-02-07
Granted: 2009-06-24
Abstract: A method is provided to treat inflammatory bowel disease by locally administering to the colon an effective amount of nicotine or a pharmaceutically acceptable salt thereof, preferably via formulations adapted for delayed oral release or rectal administration. Further provided is a novel formulation for the oral administration of nicotine comprising a polyacrylic polymer complexed with nicotine.